美国药剂师要求进行监管改革,以解决供应链问题和过时法律造成的药物普遍短缺问题。 U.S. pharmacists demand regulatory reform to address widespread drug shortages caused by supply chain issues and outdated laws.

美国各地药剂师都在敦促立法者在报告基本药品普遍短缺、供应链问题、制造业延误以及阻碍快速反应的过时法律之后,改革法规。 Pharmacists across the U.S. are urging lawmakers to reform regulations after reporting widespread shortages of essential medications, citing supply chain issues, manufacturing delays, and outdated laws that hinder rapid response. 他们警告说,现行政策使得难以获得关键药物,使病人的护理面临风险,并增加了保健提供者的负担。 They warn that current policies make it difficult to secure critical drugs, putting patient care at risk and increasing the burden on healthcare providers. 修改立法的呼吁强调,需要制定更灵活的进口规则,提高毒品生产的透明度,加强监督,以防止今后出现短缺。 The call for legislative change emphasizes the need for more flexible import rules, improved transparency in drug production, and stronger oversight to prevent future shortages.